4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001193125-25-240437
General Counsel and Secretary sold 1,076 shares at $66.60 ($71,662)
- General Counsel and Secretary acquired 2,114 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
KASINGER JAMES R. · General Counsel and Secretary
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-10-13 | Exercise or conversion : show line 1 in the form | +2,114 | 84,478 | D | ||
| 2025-10-14 | Sale : show line 2 in the form | −1,076 | $66.60 | $71,662 | 83,402 | D |
| Open-market sales · 1,076 sh · avg $66.60 · $71,662 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-10-13 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −2,114 | 2,113 | D |
Loading xslF345X05/ownership.xml…